Literature DB >> 7542600

Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells.

M A Poul1, M Cerutti, H Chaabihi, M Ticchioni, F X Deramoudt, A Bernard, G Devauchelle, M Kaczorek, M P Lefranc.   

Abstract

Plasmid cassette-transfer vectors pBHuC chi and pBHuC gamma l have been designed which enable the construction of recombinant baculoviruses directing the co-expression of complete immunoglobulin in insect cells. We describe the application of these vectors for the expression of a human/mouse chimeric monoclonal antibody of potential immunosuppressive clinical value derived from a mouse anti-human CD29 monoclonal antibody (Mu-K20). The chimeric K20 light and heavy chains produced in sf9 insect cells were correctly processed and assembled into a normal immunoglobulin which is secreted into the culture medium of infected cells. The chimeric mAb Ch-K20-sf9 reproduces in vitro the functional properties of the parental mouse K20, including affinity and inhibition of lymphocyte proliferation. These results demonstrate that the baculovirus/insect cell expression system is suitable for the expression of fully active monoclonal antibodies of therapeutic value. Our generic cassette approach makes this system a very flexible and convenient one for the rapid production of either chimeric, humanized or human mAb with heavy and light chains of any isotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542600     DOI: 10.1002/eji.1830250731

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

Review 2.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  Characterization of antibody variants during process development: the tale of incomplete processing of N-terminal secretion peptide.

Authors:  Alexandre Ambrogelly; Yan-Hui Liu; Hong Li; Selina Mengisen; Bingyi Yao; Wei Xu; Susan Cannon-Carlson
Journal:  MAbs       Date:  2012-08-29       Impact factor: 5.857

Review 4.  Genetic modification of baculovirus expression vectors.

Authors:  Shu-fen Li; Hua-lin Wang; Zhi-hong Hu; Fei Deng
Journal:  Virol Sin       Date:  2012-04-11       Impact factor: 4.327

5.  Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Authors:  Céline Monnet; Sylvie Jorieux; Nathalie Souyris; Ouafa Zaki; Alexandra Jacquet; Nathalie Fournier; Fabien Crozet; Christophe de Romeuf; Khalil Bouayadi; Rémi Urbain; Christian K Behrens; Philippe Mondon; Alexandre Fontayne
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

Review 6.  Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.

Authors:  Stanislav Sokolenko; Steve George; Andreas Wagner; Anup Tuladhar; Jonas M S Andrich; Marc G Aucoin
Journal:  Biotechnol Adv       Date:  2012-01-28       Impact factor: 14.227

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.